✦ LIBER ✦

Adult liver transplantation using live ABO-incompatible grafts in western countries

✍ Scribed by Yasuhiko Sugawara; Masatoshi Makuuchi

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 58 KB
Volume: 12
Category: Article
ISSN: 1527-6465
DOI: 10.1002/lt.20816

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Exchange living donor liver transplantat

Exchange living donor liver transplantation to overcome ABO incompatibility in adult patients

✍ Shin Hwang; Sung-Gyu Lee; Deok-Bog Moon; Gi-Won Song; Chul-Soo Ahn; Ki-Hun Kim; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 424 KB 👁 2 views

ABO incompatibility is the most common cause of donor rejection during the initial screening of adult patients with end-stage liver disease for living donor liver transplantation (LDLT). A paired donor exchange program was initiated to cope with this problem without ABO-incompatible LDLT. We present

Present status of ABO-incompatible livin

Present status of ABO-incompatible living donor liver transplantation in Japan

✍ Hiroto Egawa; Satoshi Teramukai; Hironori Haga; Minoru Tanabe; Masanori Fukushim 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 306 KB 👁 2 views

ABO-incompatible (ABO-I) living donor liver transplantation (LDLT) has been performed in Japan to overcome the organ shortage. Reported herein are the results of this approach through March 2006 in the National Registry of the Japan Study Group for ABO-incompatible transplantation. The questionnaire

The role of immunomodulation in ABO-inco

The role of immunomodulation in ABO-incompatible adult liver transplant recipients

✍ Lucio Urbani; Alessandro Mazzoni; Irene Bianco; Tiziana Grazzini; Paolo De Simon 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 1 views

## Abstract ## Background: ABO‐incompatible (ABO‐i) liver transplantation (LT) is a high‐risk procedure due to the potential for antibody‐mediated rejection (AMR) and cell‐mediated rejection. The aim of the current report is to illustrate the results of a retrospective comparison study on the use

Feasibility of ABO-incompatible living d

Feasibility of ABO-incompatible living donor liver transplantation in the rituximab era

✍ Toru Ikegami; Ken Shirabe; Yuji Soejima; Akinobu Taketomi; Yoshihiko Maehara 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB 👁 1 views

We read with interest the articles by Chan et al. 1 (Queen Mary Hospital) and Hwang et al. 2 (Asan Medical Center), who discussed the use of donor exchange programs for living donor liver transplantation (LDLT) to avoid ABO-incompatible (ABOi) LDLT because the outcomes of ABOi LDLT are very poor. H

Dual living donor liver transplantation

Dual living donor liver transplantation with ABO-incompatible and ABO-compatible grafts to overcome small-for-size graft and ABO blood group barrier

✍ Gi-Won Song; Sung-Gyu Lee; Shin Hwang; Ki-Hum Kim; Chul-Soo Ahn; Deok-Bog Moon; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB 👁 1 views

ABO blood group compatibility has been regarded as an essential prerequisite for successful adult living donor liver transplantation (LDLT). Novel strategies for overcoming the ABO blood group barrier, however, have markedly improved the results of ABO-incompatible (ABOi) LDLT. We describe our strat

B-cell surface marker analysis for impro

B-cell surface marker analysis for improvement of rituximab prophylaxis in ABO-incompatible adult living donor liver transplantation

✍ Hiroto Egawa; Katsuyuki Ohmori; Hironori Haga; Hiroaki Tsuji; Kimiko Yurugi; Aya 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 264 KB 👁 2 views

Although the effectiveness of rituximab has been reported in ABO blood group (ABO)-incompatible (ABO-I) organ transplantation, the protocol is not yet established. We studied the impact of the timing of rituximab prophylaxis and the humoral immune response of patients undergoing ABO-I living donor l